| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12017-016-8396-8 |
| P698 | PubMed publication ID | 27119371 |
| P50 | author | Claudia Ricci | Q43121043 |
| Stefania Battistini | Q43121050 | ||
| P2093 | author name string | Fabio Giannini | |
| Ammar Al-Chalabi | |||
| Ashley R Jones | |||
| Michele Benigni | |||
| P2860 | cites work | Translational biomarkers of neurotoxicity: a Health and Environmental Sciences Institute perspective on the way forward | Q23920632 |
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| The involvement of microRNAs in neurodegenerative diseases | Q26858788 | ||
| Neuronal dark matter: the emerging role of microRNAs in neurodegeneration | Q26859224 | ||
| MicroRNA profiling: approaches and considerations | Q26861675 | ||
| State of play in amyotrophic lateral sclerosis genetics | Q26864816 | ||
| MicroRNA Regulation of Brain Tumour Initiating Cells in Central Nervous System Tumours | Q27002604 | ||
| MicroRNAs as biomarkers for CNS disease | Q27013998 | ||
| Regulation by miR181 family of the dependence receptor CDON tumor suppressive activity in neuroblastoma | Q28249685 | ||
| hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells | Q28291188 | ||
| miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors | Q28307352 | ||
| Cerebrospinal fluid MicroRNA profiling using quantitative real time PCR | Q28655943 | ||
| El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis | Q29619074 | ||
| Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology | Q33567669 | ||
| Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing | Q34633640 | ||
| MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells | Q34842477 | ||
| MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development | Q35036059 | ||
| MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease | Q35629123 | ||
| Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma | Q35633805 | ||
| miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients | Q35694536 | ||
| Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma. | Q35854013 | ||
| In vivo microRNA detection and quantitation in cerebrospinal fluid | Q35992237 | ||
| MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity | Q36010084 | ||
| Plasma microRNA biomarkers for detection of mild cognitive impairment | Q36380583 | ||
| Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis | Q37485809 | ||
| MicroRNAs: synthesis, mechanism, function, and recent clinical trials | Q37771482 | ||
| Clinical genetics of amyotrophic lateral sclerosis: what do we really know? | Q37944428 | ||
| The changing scene of amyotrophic lateral sclerosis | Q38086771 | ||
| Biobanking of CSF: international standardization to optimize biomarker development | Q38175679 | ||
| RNA metabolism in ALS: when normal processes become pathological. | Q38189807 | ||
| Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges | Q38260359 | ||
| Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era. | Q38431759 | ||
| Vulnerability of microRNA biogenesis in FTD-ALS. | Q38700225 | ||
| Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers | Q39134104 | ||
| Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways | Q39975165 | ||
| Serum microRNAs in sporadic amyotrophic lateral sclerosis. | Q40769475 | ||
| MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid. | Q44001848 | ||
| miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs | Q46212323 | ||
| A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis. | Q48405373 | ||
| miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients. | Q48600153 | ||
| Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes | Q83879348 | ||
| Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study | Q85217159 | ||
| P433 | issue | 4 | |
| P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
| biomarker | Q864574 | ||
| P304 | page(s) | 551-560 | |
| P577 | publication date | 2016-04-27 | |
| P1433 | published in | NeuroMolecular Medicine | Q15716731 |
| P1476 | title | Identification of miRNAs as Potential Biomarkers in Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients | |
| P478 | volume | 18 |
| Q64269328 | A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS |
| Q64120844 | An Overview of MicroRNAs as Biomarkers of ALS |
| Q92723464 | Are Circulating Cytokines Reliable Biomarkers for Amyotrophic Lateral Sclerosis? |
| Q64079969 | Biomarkers in Motor Neuron Disease: A State of the Art Review |
| Q94560701 | Circulating MicroRNAs as Diagnostic Biomarkers for Motor Neuron Disease |
| Q91864320 | Comparative proteomes change and possible role in different pathways of microRNA-21a-5p in a mouse model of spinal cord injury |
| Q60632864 | Cortical Neurotoxic Astrocytes with Early ALS Pathology and miR-146a Deficit Replicate Gliosis Markers of Symptomatic SOD1G93A Mouse Model |
| Q50993029 | Epigenetic Mechanisms of Gene Regulation in Amyotrophic Lateral Sclerosis. |
| Q55282282 | Exploring microRNA Biomarker for Amyotrophic Lateral Sclerosis. |
| Q60044003 | Expression of microRNAs in cerebrospinal fluid of dogs with central nervous system disease |
| Q99417473 | Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides |
| Q39033841 | Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis |
| Q50421340 | Hippocampal MicroRNAs Respond to Administration of Antidepressant Fluoxetine in Adult Mice. |
| Q60912431 | Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid |
| Q37549540 | M1 and M2 Functional Imprinting of Primary Microglia: Role of P2X7 Activation and miR-125b |
| Q59791047 | MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis |
| Q64249164 | MicroRNAs as regulators of cell death mechanisms in amyotrophic lateral sclerosis |
| Q39316843 | MotomiRs: miRNAs in Motor Neuron Function and Disease |
| Q91629118 | Panoramic Visualization of Circulating MicroRNAs Across Neurodegenerative Diseases in Humans |
| Q94450925 | Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis |
| Q64084849 | Small Non-coding RNAs: New Class of Biomarkers and Potential Therapeutic Targets in Neurodegenerative Disease |
| Q48505093 | Small RNA Sequencing of Sporadic Amyotrophic Lateral Sclerosis Cerebrospinal Fluid Reveals Differentially Expressed miRNAs Related to Neural and Glial Activity. |
| Q58556997 | The Role of MicroRNAs in Patients with Amyotrophic Lateral Sclerosis |
Search more.